NASDAQ Health Care Index (IXHC) Market Capitalization
Explore all companies in the NASDAQ Health Care Index ranked by market capitalization
Total Market Cap: $2.20 Trillion Constituents: 976 Country: USA
Total Market Cap (USD)
$2.20 Trillion
Constituent Companies
976
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 201 |
Relay Therapeutics Inc
NASDAQ:RLAY |
% | $1.02 Billion | Healthcare | Biotechnology | $9.93 | -3.22% |
| 202 |
Trevi Therapeutics Inc
NASDAQ:TRVI |
% | $1.02 Billion | Healthcare | Biotechnology | $10.69 | -4.47% |
| 203 |
Nanobiotix
NASDAQ:NBTX |
% | $1.01 Billion | Healthcare | Biotechnology | $32.65 | +1.78% |
| 204 |
Vir Biotechnology Inc
NASDAQ:VIR |
% | $957.35 Million | Healthcare | Biotechnology | $9.32 | -1.69% |
| 205 |
Collegium Pharmaceutical Inc
NASDAQ:COLL |
% | $936.42 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $34.80 | -2.58% |
| 206 |
Harrow Health Inc
NASDAQ:HROW |
% | $936.17 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $34.48 | -2.13% |
| 207 |
Enliven Therapeutics Inc.
NASDAQ:ELVN |
% | $930.06 Million | Healthcare | Biotechnology | $27.25 | -1.94% |
| 208 |
Adapthealth Corp
NASDAQ:AHCO |
% | $916.00 Million | Healthcare | Medical Devices | $10.47 | +0.19% |
| 209 |
Fortrea Holdings Inc.
NASDAQ:FTRE |
% | $913.11 Million | Healthcare | Biotechnology | $9.94 | +2.47% |
| 210 |
NeoGenomics Inc
NASDAQ:NEO |
% | $904.33 Million | Healthcare | Diagnostics & Research | $8.01 | -3.14% |
| 211 |
Corvus Pharmaceuticals Inc
NASDAQ:CRVS |
% | $903.78 Million | Healthcare | Biotechnology | $14.08 | -8.87% |
| 212 |
Xeris Pharmaceuticals Inc
NASDAQ:XERS |
% | $889.00 Million | Healthcare | Biotechnology | $5.43 | -3.21% |
| 213 |
Azenta Inc
NASDAQ:AZTA |
% | $876.88 Million | Healthcare | Medical Instruments & Supplies | $21.57 | -2.09% |
| 214 |
Pharvaris BV
NASDAQ:PHVS |
% | $875.92 Million | Healthcare | Biotechnology | $26.17 | -2.79% |
| 215 |
ARS Pharmaceuticals, Inc
NASDAQ:SPRY |
% | $874.81 Million | Healthcare | Biotechnology | $8.30 | -6.64% |
| 216 |
CareDx Inc
NASDAQ:CDNA |
% | $867.74 Million | Healthcare | Diagnostics & Research | $17.38 | -1.25% |
| 217 |
Eyepoint Pharmaceuticals Inc
NASDAQ:EYPT |
% | $843.84 Million | Healthcare | Biotechnology | $13.64 | -1.87% |
| 218 |
CureVac NV
NASDAQ:CVAC |
% | $842.41 Million | Healthcare | Biotechnology | $4.66 | -0.21% |
| 219 |
Geron Corporation
NASDAQ:GERN |
% | $831.27 Million | Healthcare | Biotechnology | $1.55 | -4.32% |
| 220 |
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN |
% | $831.13 Million | Healthcare | Medical Instruments & Supplies | $20.94 | -2.60% |
| 221 |
Iradimed Co
NASDAQ:IRMD |
% | $818.20 Million | Healthcare | Medical Devices | $99.67 | -3.04% |
| 222 |
Rapport Therapeutics, Inc. Common Stock
NASDAQ:RAPP |
% | $810.78 Million | Healthcare | Biotechnology | $26.48 | -4.51% |
| 223 |
Olema Pharmaceuticals Inc
NASDAQ:OLMA |
% | $805.92 Million | Healthcare | Biotechnology | $14.57 | -3.25% |
| 224 |
MBX Biosciences, Inc. Common Stock
NASDAQ:MBX |
% | $787.65 Million | Healthcare | Biotechnology | $28.70 | -3.50% |
| 225 |
Taysha Gene Therapies Inc
NASDAQ:TSHA |
% | $787.59 Million | Healthcare | Biotechnology | $4.45 | -2.63% |
| 226 |
MannKind Corp
NASDAQ:MNKD |
% | $786.22 Million | Healthcare | Biotechnology | $2.61 | -4.40% |
| 227 |
Tilray Inc
NASDAQ:TLRY |
% | $777.93 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $6.73 | -3.17% |
| 228 |
BioLife Solutions Inc
NASDAQ:BLFS |
% | $772.74 Million | Healthcare | Medical Instruments & Supplies | $19.12 | -1.44% |
| 229 |
Clover Health Investments Corp
NASDAQ:CLOV |
% | $768.43 Million | Healthcare | Healthcare Plans | $1.88 | -2.59% |
| 230 |
Pacira BioSciences, Inc.
NASDAQ:PCRX |
% | $767.53 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $22.02 | +0.36% |
| 231 |
InMode Ltd
NASDAQ:INMD |
% | $759.63 Million | Healthcare | Medical Devices | $13.45 | -1.47% |
| 232 |
Palvella Therapeutics, Inc
NASDAQ:PVLA |
% | $752.31 Million | Healthcare | Biotechnology | $114.23 | -5.44% |
| 233 |
Omeros Corporation
NASDAQ:OMER |
% | $747.12 Million | Healthcare | Biotechnology | $10.95 | -2.84% |
| 234 |
Kodiak Sciences Inc
NASDAQ:KOD |
% | $738.04 Million | Healthcare | Biotechnology | $22.08 | -7.42% |
| 235 |
Abcellera Biologics Inc
NASDAQ:ABCL |
% | $731.78 Million | Healthcare | Biotechnology | $3.52 | -0.85% |
| 236 |
Zenas BioPharma, Inc. Common Stock
NASDAQ:ZBIO |
% | $730.81 Million | Healthcare | Biotechnology | $23.03 | -1.92% |
| 237 |
Monte Rosa Therapeutics Inc
NASDAQ:GLUE |
% | $730.77 Million | Healthcare | Biotechnology | $15.76 | -1.68% |
| 238 |
Verve Therapeutics Inc
NASDAQ:VERV |
% | $727.51 Million | Healthcare | Biotechnology | $11.13 | +0.00% |
| 239 |
Astria Therapeutics Inc
NASDAQ:ATXS |
% | $718.13 Million | Healthcare | Biotechnology | $5784.30 | +45880.13% |
| 240 |
UroGen Pharma Ltd
NASDAQ:URGN |
% | $714.37 Million | Healthcare | Biotechnology | $18.48 | -0.59% |
| 241 |
Oric Pharmaceuticals Inc
NASDAQ:ORIC |
% | $691.53 Million | Healthcare | Biotechnology | $10.86 | -10.02% |
| 242 |
Tyra Biosciences Inc
NASDAQ:TYRA |
% | $689.54 Million | Healthcare | Biotechnology | $38.05 | +0.34% |
| 243 |
Castle Biosciences Inc
NASDAQ:CSTL |
% | $689.04 Million | Healthcare | Diagnostics & Research | $25.62 | -1.10% |
| 244 |
Surgery Partners Inc
NASDAQ:SGRY |
% | $686.97 Million | Healthcare | Medical Care Facilities | $12.36 | -2.29% |
| 245 |
Chimerix Inc
NASDAQ:CMRX |
% | $686.96 Million | Healthcare | Biotechnology | $8.54 | -0.12% |
| 246 |
Uniqure NV
NASDAQ:QURE |
% | $677.48 Million | Healthcare | Biotechnology | $14.73 | -5.70% |
| 247 |
Ventyx Biosciences Inc
NASDAQ:VTYX |
% | $669.96 Million | Healthcare | Biotechnology | $14.00 | +0.00% |
| 248 |
Talkspace Inc
NASDAQ:TALK |
% | $649.77 Million | Healthcare | Health Information Services | $5.13 | -0.19% |
| 249 |
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX |
% | $649.06 Million | Healthcare | Biotechnology | $18.41 | -4.71% |
| 250 |
Amphastar P
NASDAQ:AMPH |
% | $648.28 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $19.00 | -2.61% |
Complete list of all companies in the IXHC index ranked by market capitalization. Track index constituent performance and market values. View all indices